HK1 and breast cancer: The initial rate-limiting enzymes of glycolysis, hexokinase 1 (HK1) and hexokinase 2 (HK2), are markedly overexpressed in breast cancer, with the suppression of HK expression leading to the dampening of breast cancer cell proliferation, invasion, and migration (71).